Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)

Rachel Syme,Da Stewart,M Rodriguez-Galvez,Joanne Luider,Y Auer,J Klassen,Don Morris,Christopher B. Brown,James A. Russell,Stefan Gluck

Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)

2003

Rachel Syme
Da Stewart
M Rodriguez-Galvez
Joanne Luider
Y Auer
J Klassen
Don Morris
Christopher B. Brown
James A. Russell
Stefan Gluck

Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)

Keywords:

Breast cancer
Mammary gland
Immunology
Micrometastasis
Cancer
Stem cell
Transplantation
Medicine
Cytokeratin
Chemotherapy
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations